Adaptimmune Therapeutics Plc
ADAP
Revenue
128.23M
▲122.55M▲2158.38%
3 Months ChangeAssets
321.70M
▲63.69M▲24.69%
3 Months ChangeLiabilities
225.43M
▼-8.21M▼-3.51%
3 Months ChangeFree Cash Flow
-32.05M
▲7.58M▲19.13%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001558370-24-014148
2024-09-23
Form 8-K
ID: 0001558370-24-012960
2024-08-12
Form 10-Q
ID: 0001558370-24-011798
2024-08-12
Form 8-K
ID: 0001558370-24-011793
2024-08-02
Form 8-K
ID: 0001104659-24-085098
2024-07-16
Form 8-K
ID: 0001558370-24-009854
2024-06-11
Form 8-K
ID: 0001558370-24-009053
2024-05-30
Form 8-K
ID: 0001558370-24-008778
2024-05-15
Form 10-Q
ID: 0001558370-24-008287
2024-05-15
Form 8-K
ID: 0001558370-24-008210